SKILLMAN, N.J., Dec. 6, 2010 /PRNewswire/ — ConvaTec
Healthcare, a world-leading developer, manufacturer and marketer of
innovative medical technologies for community and hospital care,
today announced that in connection with a refinancing of its debt
under its existing senior secured and mezzanine facilities and in
combination with new senior secured credit facilities, it is
offering $1,870,000,000 (equivalent) in Senior Secured Notes and
Senior Notes. The offering of the new notes will not be registered
under the Securities Act or any state securities laws and the new
notes may not be offered or sold in the United States absent
registration or an applicable exemption from the registration
requirements of the Securities Act of 1933, as amended and
applicable state securities laws.
About ConvaTec ConvaTec is a leading developer and marketer
of innovative medical technologies. With four key focus areas
– Ostomy Care, Wound Therapeutics, Continence and Critical
Care, and Infusion Devices – ConvaTec products support
healthcare professionals from the hospital to the community health
setting. From its operational headquarters in Skillman, New Jersey,
the company conducts business in over 100 countries, serving
consumers and their health care professionals on six continents.
For more information, please visit www.convatec.com.
Certain statements in this press release are forward-looking
statements within the meaning of the Private Securities Litigation
Reform Act of 1995. Forward looking statements are all statements
other than statements of historical facts. Certain of these forward
looking statements are identified by terminology such as “aim,”
“anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,”
“forecast,” “guidance,” “intend,” “may,” “plan,” “potential,”
“predict,” “projected,” “should,” or “will” or the negative of such
terms or other comparable terminology. Others can be identi
‘/>”/>
SOURCE